0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Ophthalmic Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-23T13321
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Ophthalmic Drugs Market Research Report 2023
BUY CHAPTERS

Global Veterinary Ophthalmic Drugs Market Research Report 2025

Code: QYRE-Auto-23T13321
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Ophthalmic Drugs Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Veterinary Ophthalmic Drugs Market

Veterinary Ophthalmic Drugs Market

The global market for Veterinary Ophthalmic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 146%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Ophthalmic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Ophthalmic Drugs.
The Veterinary Ophthalmic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Ophthalmic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Ophthalmic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Ophthalmic Drugs Market Report

Report Metric Details
Report Name Veterinary Ophthalmic Drugs Market
Accounted market size in 2021 $ 38.3 billion
Base Year 2021
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Household
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ecoanolytes Ltd., Shayana Healthcare Pvt Ltd., Akorn Animal Health, Epicur Pharma, Sentrx Animal Care, an-vision, GMT Pharma International, Vee Remedies, AdvaCare Pharma, Elanco, Vetoquinol SA, Inovet, Sterling Pharmaceutical Services, Recipeharm, Dechra Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Ophthalmic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Ophthalmic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Veterinary Ophthalmic Drugs Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

What is the Veterinary Ophthalmic Drugs Market share by application?

Ans: From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%.

Who are the main players in the Veterinary Ophthalmic Drugs Market report?

Ans: The main players in the Veterinary Ophthalmic Drugs Market are Ecoanolytes Ltd., Shayana Healthcare Pvt Ltd., Akorn Animal Health, Epicur Pharma, Sentrx Animal Care, an-vision, GMT Pharma International, Vee Remedies, AdvaCare Pharma, Elanco, Vetoquinol SA, Inovet, Sterling Pharmaceutical Services, Recipeharm, Dechra Pharmaceuticals

What are the Application segmentation covered in the Veterinary Ophthalmic Drugs Market report?

Ans: The Applications covered in the Veterinary Ophthalmic Drugs Market report are Hospital, Clinic, Household, Other

What are the Type segmentation covered in the Veterinary Ophthalmic Drugs Market report?

Ans: The Types covered in the Veterinary Ophthalmic Drugs Market report are Veterinary Eye Drops, Veterinary Eye Ointment

Recommended Reports

Veterinary Pharmaceuticals

Veterinary Equipment

Animal Health & Nutrition

1 Veterinary Ophthalmic Drugs Market Overview
1.1 Product Definition
1.2 Veterinary Ophthalmic Drugs by Type
1.2.1 Global Veterinary Ophthalmic Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Veterinary Eye Drops
1.2.3 Veterinary Eye Ointment
1.3 Veterinary Ophthalmic Drugs by Application
1.3.1 Global Veterinary Ophthalmic Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Other
1.4 Global Veterinary Ophthalmic Drugs Market Size Estimates and Forecasts
1.4.1 Global Veterinary Ophthalmic Drugs Revenue 2020-2031
1.4.2 Global Veterinary Ophthalmic Drugs Sales 2020-2031
1.4.3 Global Veterinary Ophthalmic Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Ophthalmic Drugs Market Competition by Manufacturers
2.1 Global Veterinary Ophthalmic Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Ophthalmic Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Ophthalmic Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Ophthalmic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Ophthalmic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Ophthalmic Drugs, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Ophthalmic Drugs, Date of Enter into This Industry
2.8 Global Veterinary Ophthalmic Drugs Market Competitive Situation and Trends
2.8.1 Global Veterinary Ophthalmic Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Ophthalmic Drugs Players Market Share by Revenue
2.8.3 Global Veterinary Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Ophthalmic Drugs Market Scenario by Region
3.1 Global Veterinary Ophthalmic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Ophthalmic Drugs Sales by Region: 2020-2031
3.2.1 Global Veterinary Ophthalmic Drugs Sales by Region: 2020-2025
3.2.2 Global Veterinary Ophthalmic Drugs Sales by Region: 2026-2031
3.3 Global Veterinary Ophthalmic Drugs Revenue by Region: 2020-2031
3.3.1 Global Veterinary Ophthalmic Drugs Revenue by Region: 2020-2025
3.3.2 Global Veterinary Ophthalmic Drugs Revenue by Region: 2026-2031
3.4 North America Veterinary Ophthalmic Drugs Market Facts & Figures by Country
3.4.1 North America Veterinary Ophthalmic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Ophthalmic Drugs Sales by Country (2020-2031)
3.4.3 North America Veterinary Ophthalmic Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Ophthalmic Drugs Market Facts & Figures by Country
3.5.1 Europe Veterinary Ophthalmic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Ophthalmic Drugs Sales by Country (2020-2031)
3.5.3 Europe Veterinary Ophthalmic Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Ophthalmic Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Ophthalmic Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Ophthalmic Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Ophthalmic Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Ophthalmic Drugs Market Facts & Figures by Country
3.7.1 Latin America Veterinary Ophthalmic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Ophthalmic Drugs Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Ophthalmic Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Ophthalmic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Ophthalmic Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Ophthalmic Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Ophthalmic Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Ophthalmic Drugs Sales by Type (2020-2031)
4.1.1 Global Veterinary Ophthalmic Drugs Sales by Type (2020-2025)
4.1.2 Global Veterinary Ophthalmic Drugs Sales by Type (2026-2031)
4.1.3 Global Veterinary Ophthalmic Drugs Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Ophthalmic Drugs Revenue by Type (2020-2031)
4.2.1 Global Veterinary Ophthalmic Drugs Revenue by Type (2020-2025)
4.2.2 Global Veterinary Ophthalmic Drugs Revenue by Type (2026-2031)
4.2.3 Global Veterinary Ophthalmic Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Ophthalmic Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Ophthalmic Drugs Sales by Application (2020-2031)
5.1.1 Global Veterinary Ophthalmic Drugs Sales by Application (2020-2025)
5.1.2 Global Veterinary Ophthalmic Drugs Sales by Application (2026-2031)
5.1.3 Global Veterinary Ophthalmic Drugs Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Ophthalmic Drugs Revenue by Application (2020-2031)
5.2.1 Global Veterinary Ophthalmic Drugs Revenue by Application (2020-2025)
5.2.2 Global Veterinary Ophthalmic Drugs Revenue by Application (2026-2031)
5.2.3 Global Veterinary Ophthalmic Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Ophthalmic Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ecoanolytes Ltd.
6.1.1 Ecoanolytes Ltd. Company Information
6.1.2 Ecoanolytes Ltd. Description and Business Overview
6.1.3 Ecoanolytes Ltd. Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ecoanolytes Ltd. Veterinary Ophthalmic Drugs Product Portfolio
6.1.5 Ecoanolytes Ltd. Recent Developments/Updates
6.2 Shayana Healthcare Pvt Ltd.
6.2.1 Shayana Healthcare Pvt Ltd. Company Information
6.2.2 Shayana Healthcare Pvt Ltd. Description and Business Overview
6.2.3 Shayana Healthcare Pvt Ltd. Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shayana Healthcare Pvt Ltd. Veterinary Ophthalmic Drugs Product Portfolio
6.2.5 Shayana Healthcare Pvt Ltd. Recent Developments/Updates
6.3 Akorn Animal Health
6.3.1 Akorn Animal Health Company Information
6.3.2 Akorn Animal Health Description and Business Overview
6.3.3 Akorn Animal Health Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Akorn Animal Health Veterinary Ophthalmic Drugs Product Portfolio
6.3.5 Akorn Animal Health Recent Developments/Updates
6.4 Epicur Pharma
6.4.1 Epicur Pharma Company Information
6.4.2 Epicur Pharma Description and Business Overview
6.4.3 Epicur Pharma Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Epicur Pharma Veterinary Ophthalmic Drugs Product Portfolio
6.4.5 Epicur Pharma Recent Developments/Updates
6.5 Sentrx Animal Care
6.5.1 Sentrx Animal Care Company Information
6.5.2 Sentrx Animal Care Description and Business Overview
6.5.3 Sentrx Animal Care Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sentrx Animal Care Veterinary Ophthalmic Drugs Product Portfolio
6.5.5 Sentrx Animal Care Recent Developments/Updates
6.6 an-vision
6.6.1 an-vision Company Information
6.6.2 an-vision Description and Business Overview
6.6.3 an-vision Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 an-vision Veterinary Ophthalmic Drugs Product Portfolio
6.6.5 an-vision Recent Developments/Updates
6.7 GMT Pharma International
6.7.1 GMT Pharma International Company Information
6.7.2 GMT Pharma International Description and Business Overview
6.7.3 GMT Pharma International Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GMT Pharma International Veterinary Ophthalmic Drugs Product Portfolio
6.7.5 GMT Pharma International Recent Developments/Updates
6.8 Vee Remedies
6.8.1 Vee Remedies Company Information
6.8.2 Vee Remedies Description and Business Overview
6.8.3 Vee Remedies Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vee Remedies Veterinary Ophthalmic Drugs Product Portfolio
6.8.5 Vee Remedies Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Company Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AdvaCare Pharma Veterinary Ophthalmic Drugs Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Company Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elanco Veterinary Ophthalmic Drugs Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Vetoquinol SA
6.11.1 Vetoquinol SA Company Information
6.11.2 Vetoquinol SA Description and Business Overview
6.11.3 Vetoquinol SA Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vetoquinol SA Veterinary Ophthalmic Drugs Product Portfolio
6.11.5 Vetoquinol SA Recent Developments/Updates
6.12 Inovet
6.12.1 Inovet Company Information
6.12.2 Inovet Description and Business Overview
6.12.3 Inovet Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Inovet Veterinary Ophthalmic Drugs Product Portfolio
6.12.5 Inovet Recent Developments/Updates
6.13 Sterling Pharmaceutical Services
6.13.1 Sterling Pharmaceutical Services Company Information
6.13.2 Sterling Pharmaceutical Services Description and Business Overview
6.13.3 Sterling Pharmaceutical Services Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sterling Pharmaceutical Services Veterinary Ophthalmic Drugs Product Portfolio
6.13.5 Sterling Pharmaceutical Services Recent Developments/Updates
6.14 Recipeharm
6.14.1 Recipeharm Company Information
6.14.2 Recipeharm Description and Business Overview
6.14.3 Recipeharm Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Recipeharm Veterinary Ophthalmic Drugs Product Portfolio
6.14.5 Recipeharm Recent Developments/Updates
6.15 Dechra Pharmaceuticals
6.15.1 Dechra Pharmaceuticals Company Information
6.15.2 Dechra Pharmaceuticals Description and Business Overview
6.15.3 Dechra Pharmaceuticals Veterinary Ophthalmic Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Dechra Pharmaceuticals Veterinary Ophthalmic Drugs Product Portfolio
6.15.5 Dechra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Ophthalmic Drugs Industry Chain Analysis
7.2 Veterinary Ophthalmic Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Ophthalmic Drugs Production Mode & Process Analysis
7.4 Veterinary Ophthalmic Drugs Sales and Marketing
7.4.1 Veterinary Ophthalmic Drugs Sales Channels
7.4.2 Veterinary Ophthalmic Drugs Distributors
7.5 Veterinary Ophthalmic Drugs Customer Analysis
8 Veterinary Ophthalmic Drugs Market Dynamics
8.1 Veterinary Ophthalmic Drugs Industry Trends
8.2 Veterinary Ophthalmic Drugs Market Drivers
8.3 Veterinary Ophthalmic Drugs Market Challenges
8.4 Veterinary Ophthalmic Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Ophthalmic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Ophthalmic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Ophthalmic Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Ophthalmic Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Ophthalmic Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Ophthalmic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Ophthalmic Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Ophthalmic Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Ophthalmic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Ophthalmic Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Ophthalmic Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Ophthalmic Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Ophthalmic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Ophthalmic Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Ophthalmic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Ophthalmic Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Veterinary Ophthalmic Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Ophthalmic Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Veterinary Ophthalmic Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Ophthalmic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Ophthalmic Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Ophthalmic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Ophthalmic Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Ophthalmic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Ophthalmic Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Veterinary Ophthalmic Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Veterinary Ophthalmic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Ophthalmic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Ophthalmic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Ophthalmic Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Veterinary Ophthalmic Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Veterinary Ophthalmic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Ophthalmic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Ophthalmic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Ophthalmic Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Veterinary Ophthalmic Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Veterinary Ophthalmic Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Ophthalmic Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Ophthalmic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Ophthalmic Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Veterinary Ophthalmic Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Veterinary Ophthalmic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Ophthalmic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Ophthalmic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Ophthalmic Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Veterinary Ophthalmic Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Veterinary Ophthalmic Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Ophthalmic Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Ophthalmic Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Veterinary Ophthalmic Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Veterinary Ophthalmic Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Ophthalmic Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Ophthalmic Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Ophthalmic Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Ophthalmic Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Ophthalmic Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Ophthalmic Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Ophthalmic Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Ophthalmic Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Veterinary Ophthalmic Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Veterinary Ophthalmic Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Ophthalmic Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Ophthalmic Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Ophthalmic Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Ophthalmic Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Ophthalmic Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Ophthalmic Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Ophthalmic Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Ecoanolytes Ltd. Company Information
 Table 71. Ecoanolytes Ltd. Description and Business Overview
 Table 72. Ecoanolytes Ltd. Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Ecoanolytes Ltd. Veterinary Ophthalmic Drugs Product
 Table 74. Ecoanolytes Ltd. Recent Developments/Updates
 Table 75. Shayana Healthcare Pvt Ltd. Company Information
 Table 76. Shayana Healthcare Pvt Ltd. Description and Business Overview
 Table 77. Shayana Healthcare Pvt Ltd. Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Shayana Healthcare Pvt Ltd. Veterinary Ophthalmic Drugs Product
 Table 79. Shayana Healthcare Pvt Ltd. Recent Developments/Updates
 Table 80. Akorn Animal Health Company Information
 Table 81. Akorn Animal Health Description and Business Overview
 Table 82. Akorn Animal Health Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Akorn Animal Health Veterinary Ophthalmic Drugs Product
 Table 84. Akorn Animal Health Recent Developments/Updates
 Table 85. Epicur Pharma Company Information
 Table 86. Epicur Pharma Description and Business Overview
 Table 87. Epicur Pharma Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Epicur Pharma Veterinary Ophthalmic Drugs Product
 Table 89. Epicur Pharma Recent Developments/Updates
 Table 90. Sentrx Animal Care Company Information
 Table 91. Sentrx Animal Care Description and Business Overview
 Table 92. Sentrx Animal Care Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sentrx Animal Care Veterinary Ophthalmic Drugs Product
 Table 94. Sentrx Animal Care Recent Developments/Updates
 Table 95. an-vision Company Information
 Table 96. an-vision Description and Business Overview
 Table 97. an-vision Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. an-vision Veterinary Ophthalmic Drugs Product
 Table 99. an-vision Recent Developments/Updates
 Table 100. GMT Pharma International Company Information
 Table 101. GMT Pharma International Description and Business Overview
 Table 102. GMT Pharma International Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GMT Pharma International Veterinary Ophthalmic Drugs Product
 Table 104. GMT Pharma International Recent Developments/Updates
 Table 105. Vee Remedies Company Information
 Table 106. Vee Remedies Description and Business Overview
 Table 107. Vee Remedies Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Vee Remedies Veterinary Ophthalmic Drugs Product
 Table 109. Vee Remedies Recent Developments/Updates
 Table 110. AdvaCare Pharma Company Information
 Table 111. AdvaCare Pharma Description and Business Overview
 Table 112. AdvaCare Pharma Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AdvaCare Pharma Veterinary Ophthalmic Drugs Product
 Table 114. AdvaCare Pharma Recent Developments/Updates
 Table 115. Elanco Company Information
 Table 116. Elanco Description and Business Overview
 Table 117. Elanco Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Elanco Veterinary Ophthalmic Drugs Product
 Table 119. Elanco Recent Developments/Updates
 Table 120. Vetoquinol SA Company Information
 Table 121. Vetoquinol SA Description and Business Overview
 Table 122. Vetoquinol SA Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Vetoquinol SA Veterinary Ophthalmic Drugs Product
 Table 124. Vetoquinol SA Recent Developments/Updates
 Table 125. Inovet Company Information
 Table 126. Inovet Description and Business Overview
 Table 127. Inovet Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Inovet Veterinary Ophthalmic Drugs Product
 Table 129. Inovet Recent Developments/Updates
 Table 130. Sterling Pharmaceutical Services Company Information
 Table 131. Sterling Pharmaceutical Services Description and Business Overview
 Table 132. Sterling Pharmaceutical Services Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sterling Pharmaceutical Services Veterinary Ophthalmic Drugs Product
 Table 134. Sterling Pharmaceutical Services Recent Developments/Updates
 Table 135. Recipeharm Company Information
 Table 136. Recipeharm Description and Business Overview
 Table 137. Recipeharm Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Recipeharm Veterinary Ophthalmic Drugs Product
 Table 139. Recipeharm Recent Developments/Updates
 Table 140. Dechra Pharmaceuticals Company Information
 Table 141. Dechra Pharmaceuticals Description and Business Overview
 Table 142. Dechra Pharmaceuticals Veterinary Ophthalmic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Dechra Pharmaceuticals Veterinary Ophthalmic Drugs Product
 Table 144. Dechra Pharmaceuticals Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Veterinary Ophthalmic Drugs Distributors List
 Table 148. Veterinary Ophthalmic Drugs Customers List
 Table 149. Veterinary Ophthalmic Drugs Market Trends
 Table 150. Veterinary Ophthalmic Drugs Market Drivers
 Table 151. Veterinary Ophthalmic Drugs Market Challenges
 Table 152. Veterinary Ophthalmic Drugs Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Ophthalmic Drugs
 Figure 2. Global Veterinary Ophthalmic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Ophthalmic Drugs Market Share by Type: 2024 & 2031
 Figure 4. Veterinary Eye Drops Product Picture
 Figure 5. Veterinary Eye Ointment Product Picture
 Figure 6. Global Veterinary Ophthalmic Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Veterinary Ophthalmic Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Household
 Figure 11. Other
 Figure 12. Global Veterinary Ophthalmic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Veterinary Ophthalmic Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Veterinary Ophthalmic Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Veterinary Ophthalmic Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Veterinary Ophthalmic Drugs Report Years Considered
 Figure 17. Veterinary Ophthalmic Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Veterinary Ophthalmic Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Veterinary Ophthalmic Drugs Players: Market Share by Revenue in Veterinary Ophthalmic Drugs in 2024
 Figure 20. Veterinary Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Veterinary Ophthalmic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Veterinary Ophthalmic Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Veterinary Ophthalmic Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Veterinary Ophthalmic Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Veterinary Ophthalmic Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Veterinary Ophthalmic Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Veterinary Ophthalmic Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Veterinary Ophthalmic Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Veterinary Ophthalmic Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Veterinary Ophthalmic Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Veterinary Ophthalmic Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Veterinary Ophthalmic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Veterinary Ophthalmic Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Veterinary Ophthalmic Drugs by Type (2020-2031)
 Figure 54. Global Veterinary Ophthalmic Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Veterinary Ophthalmic Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Veterinary Ophthalmic Drugs by Application (2020-2031)
 Figure 57. Global Veterinary Ophthalmic Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Veterinary Ophthalmic Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS